Showing results (11-20 of 168) with videos related to

Sort By:
Pageof 17
Oncogene|August 20, 2002
Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancersMeiko Takahashi, Tatsuhiko Tsunoda, Motoharu Seiki, et al.
Oncology Reports|August 4, 2005
Up-regulation of PSF2, a member of the GINS multiprotein complex, in intrahepatic cholangiocarcinomaKazutaka Obama, Katsuaki Ura, Seiji Satoh, et al.
BMC Cancer|August 21, 2010
Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptaseNikolaos Stefanou, Vassilis Papanikolaou, Yoichi Furukawa, et al.
Neoplasia (New York, N.Y.)|March 21, 2012
CLCA2 as a p53-inducible senescence mediatorChizu Tanikawa, Hidewaki Nakagawa, Yoichi Furukawa, et al.
Stem Cells (Dayton, Ohio)|January 5, 2021
Robust parameter design of human induced pluripotent stem cell differentiation protocols defines lineage-specific induction of anterior-posterior gut tube endodermal cellsRyota Yasui, Keisuke Sekine, Kiyoshi Yamaguchi, et al.
Oncology Reports|July 16, 2004
Isolation of LEM domain-containing 1, a novel testis-specific gene expressed in colorectal cancersDaisuke Yuki, Yu-Min Lin, Yoshitaka Fujii, et al.
Plos One|September 3, 2011
Smyd3 is required for the development of cardiac and skeletal muscle in zebrafishTomoaki Fujii, Shin-ichiro Tsunesumi, Kiyoshi Yamaguchi, et al.
Biotechnology and Bioengineering|July 30, 2017
Bidirectional reporter assay using HAL promoter and TOPFLASH improves specificity in high-throughput screening of Wnt inhibitorsKiyoshi Yamaguchi, Chi Zhu, Tomoyuki Ohsugi, et al.
International Journal of Oncology|December 5, 2003
Isolation of development and differentiation enhancing factor-like 1 (DDEFL1) as a drug target for hepatocellular carcinomasHiroshi Okabe, Yoichi Furukawa, Tatsushi Kato, et al.
International Journal of Oncology|July 6, 2006
Identification of TOMM34, which shows elevated expression in the majority of human colon cancers, as a novel drug targetTakashi Shimokawa, Satoshi Matsushima, Takuya Tsunoda, et al.
Pageof 17